
Lasa Supergenerics Ltd Falls to 52-Week Low of Rs 7 as Sell-Off Deepens
2026-03-23 12:40:45For the second consecutive session, Lasa Supergenerics Ltd has succumbed to selling pressure, hitting a fresh 52-week low of Rs 7 on 23 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance remains stark against its sector and benchmark indices.
Read full news article
Lasa Supergenerics Ltd is Rated Strong Sell
2026-03-20 10:10:18Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 March 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.
Read full news article
Lasa Supergenerics Ltd Stock Hits 52-Week Low Amid Continued Downtrend
2026-03-19 10:19:38Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.7.05 today, marking a significant decline amid persistent downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing financial and market pressures.
Read full news article
Lasa Supergenerics Ltd Falls to 52-Week Low Amid Continued Downtrend
2026-03-16 16:06:00Lasa Supergenerics Ltd has touched a new 52-week low, closing just 0.42% above its lowest price of Rs 7.13, marking a significant decline amid persistent downward momentum in the Pharmaceuticals & Biotechnology sector.
Read full news article
Lasa Supergenerics Ltd is Rated Strong Sell
2026-03-05 10:10:37Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news article
Lasa Supergenerics Ltd Stock Hits 52-Week Low at Rs.7.13
2026-03-04 12:11:37Lasa Supergenerics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.7.13, marking a significant decline in its stock price amid ongoing market pressures and company-specific financial concerns.
Read full news article
Lasa Supergenerics Ltd Stock Hits 52-Week Low Amidst Continued Downtrend
2026-03-04 12:11:34Lasa Supergenerics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a new 52-week low of Rs.7.13 today, marking a significant decline in its stock price amid ongoing market pressures and company-specific factors.
Read full news article
Lasa Supergenerics Ltd Stock Falls to 52-Week Low of Rs.7.29
2026-03-02 12:50:33Lasa Supergenerics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week and all-time low of Rs.7.29 today, marking a significant decline in its stock price amid ongoing market pressures and company-specific challenges.
Read full news article
Lasa Supergenerics Ltd Stock Hits 52-Week Low Amidst Continued Downtrend
2026-02-20 11:11:34Lasa Supergenerics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week and all-time low of Rs.7.59 today, marking a significant decline amid a broader market recovery. The stock has underperformed its sector and benchmark indices, reflecting ongoing financial pressures and subdued performance metrics.
Read full news articleResults For Quarter Ended 31St December 2025
13-Feb-2026 | Source : BSEResults for quarter ended 31st December 2025
Integrated Filing For Quarter Ended December 31 2025
13-Feb-2026 | Source : BSEIntegrated filing for quarter ended December 31 2025
Board Meeting Outcome for Outcome Of Board Meeting For Quarter Ended 31St December 2025
13-Feb-2026 | Source : BSEPursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 P.M. and concluded at 03.15 P.M. inter- alia have considered and approved the following: 1. The Unaudited Financial Results of the Company for the quarter ended December 31 2025. 2. Limited Review Report from Statutory Auditor for the quarter ended on December 31 2025.
Corporate Actions
No Upcoming Board Meetings
Lasa Supergenerics Ltd has declared 2% dividend, ex-date: 16 Sep 22
No Splits history available
No Bonus history available
No Rights history available






